Heyman Tomas J. (CIK 0001814673)

Latest company ownership

Role: Director
Shares held
42,282
Last filed at
May 30, 2025
Confidence Score
48.7
2025Q4
Confidence Score History
2025Q2 2025Q4
Shares held
9,398
Last filed at
Jun 5, 2025
Confidence Score
50.0
2025Q4
Confidence Score History
2023Q2 2025Q4

Recent buy/sell transactions

Exec date Filing date Company Role Signal Confidence Shares % of shares Under plan? Amount (USD)
May 21, 2025 May 22, 2025 EXELIXIS, INC. Director Sell 22.5 -4,544 -12.28% $201.3K
Jun 16, 2023 Jun 21, 2023 Akero Therapeutics, Inc. Director Sell 17.5 -26,000 -100.00% $1.4M